Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Tuesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 6.7 % BTX stock opened at $0.31 on Tuesday. The firm’s fifty day simple moving average is $0.34 and its two-hundred day simple […]
